Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Surgical Procedures, Operative × Endocrine × Clear all

Phase

Status

Completed 5 Unknown 2 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Breast 12 Thoracic 7 Genitourinary 6 Head & Neck 3 CNS 3 Sarcoma 2 Dermatologic 2 Tumor-Agnostic 1 Gynecologic 1 Endocrine 1

Conditions

Interventions

lutetium Lu 177 dotatate 13 Specimen Handling 9 Nivolumab 9 Magnetic Resonance Spectroscopy 9 Ipilimumab 7 pembrolizumab 6 trametinib 5 cabozantinib 5 Temozolomide 5 dabrafenib 4 Immunoglobulin G 4 Everolimus 4 Disulfides 4 selpercatinib 3 lenvatinib 3 atezolizumab 3 Lutetium-177 3 Carboplatin 3 Bevacizumab 3 entrectinib 2 copper dotatate CU-64 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Vemurafenib 2 Phantoms, Imaging 2 Paclitaxel 2 Octreotide 2 Lutetium 2 Cisplatin 2 Capecitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05735912 2026-01-13

ERASIN-RCT

Azienda Ospedaliera Universitaria Integrata Verona

Phase NA Active not recruiting

Insulinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡